top of page
The Professional Network for Healthcare Experts
European Commission approves Keytruda plus Padcev for perioperative treatment of muscle-invasive bladder cancer
The European Commission has authorised Keytruda plus Padcev before and after surgery for adults with resectable muscle-invasive bladder cancer, expanding perioperative treatment options in the EU.
nuaxia
6 hours ago2 min read
FDA Approves MSD’s Keytruda Combinations with Padcev for Muscle-Invasive Bladder Cancer
The approvals expand the use of Keytruda and Keytruda Qlex alongside Padcev into the perioperative treatment setting for adults with muscle-invasive bladder cancer.
nuaxia
Jul 134 min read
bottom of page